DOCSLIB.ORG

Mtor Target NDRG1 Confers MGMT-Dependent Resistance to Alkylating Chemotherapy

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Mtor Target NDRG1 Confers MGMT-Dependent Resistance to Alkylating Chemotherapy mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy Markus Weilera,b,c,1, Jonas Blaesa,b,1, Stefan Puscha,d,e,1, Felix Sahma,d,e, Marcus Czabankaf, Sebastian Lugera,b,c, Lukas Bunsea,c,g, Gergely Soleckia,b, Viktoria Eichwalda,h, Manfred Jugolda,h, Sibylle Hodeckera,b,c, Matthias Osswalda,b,c, Christoph Meisneri, Thomas Hielschera,j, Petra Rübmanna,h, Philipp-Niklas Pfenninga,b, Michael Ronellenfitschk, Tore Kempfl, Martina Schnölzerl, Amir Abdollahia,m, Florian Langn, Martin Bendszuso, Andreas von Deimlinga,d,e, Frank Winklera,b,c, Michael Wellerp, Peter Vajkoczyf, Michael Plattena,c,g, and Wolfgang Wicka,b,c,2 aGerman Cancer Consortium, Clinical Cooperation Units bNeurooncology and dNeuropathology, gHelmholtz Group Experimental Neuroimmunology, hSmall Animal Imaging Facility, jBiostatistics, and lFunctional Proteome Analysis, German Cancer Research Center, D-69120 Heidelberg, Germany; Departments of cNeurooncology and mRadiation Oncology, National Center for Tumor Diseases, and Departments of eNeuropathology and oNeuroradiology, University Hospital Heidelberg, D-69120 Heidelberg, Germany; fNeurosurgery Clinic Charité, University Medicine Berlin, D-13353 Berlin, Germany; iDepartment of Medical Biometry and nPhysiology, University of Tübingen, D-72076 Tübingen, Germany; kDr. Senckenberg Institute of Neurooncology, Goethe-University Hospital Frankfurt, D-60528 Frankfurt am Main, Germany; and pDepartment of Neurology, University Hospital Zurich, CH-8090 Zurich, Switzerland Edited* by Webster K. Cavenee, Ludwig Institute for Cancer Research, University of California, San Diego, La Jolla, CA, and approved December 3, 2013 (received for review July 31, 2013) A hypoxic microenvironment induces resistance to alkylating (8). The NDRG family of proteins consists of four evolutionary agents by activating targets in the mammalian target of rapamy- conserved members, NDRG1–4. The first member to be dis- cin (mTOR) pathway. The molecular mechanisms involved in this covered and responsible for the family name was NDRG1 be- mTOR-mediated hypoxia-induced chemoresistance, however, are cause its expression is repressed by the protooncogenes MYCN unclear. Here we identify the mTOR target N-myc downstream and MYC (9). It has been hypothesized that NDRG1 expression regulated gene 1 (NDRG1) as a key determinant of resistance to- is inversely correlated with survival in glioblastomas (10), but the ward alkylating chemotherapy, driven by hypoxia but also by molecular and functional mechanisms involved in this associa- therapeutic measures such as irradiation, corticosteroids, and tion remain unclear. chronic exposure to alkylating agents via distinct molecular To identify critical pathways involved in the chemoresistance routes involving hypoxia-inducible factor (HIF)-1alpha, p53, and of gliomas evoked by microenvironmental factors, particularly the mTOR complex 2 (mTORC2)/serum glucocorticoid-induced hypoxia, we initiated an unbiased proteomics approach. protein kinase 1 (SGK1) pathway. Resistance toward alkylating chemotherapy but not radiotherapy was dependent on NDRG1 Materials and Methods expression and activity. In posttreatment tumor tissue of pa- Cell Culture, Reagents, Transfections, and Treatment Regimens. Details are tients with malignant gliomas, NDRG1 was induced and pre- provided in SI Appendix, Methods. dictive of poor response to alkylating chemotherapy. On a mo- lecular level, NDRG1 bound and stabilized methyltransferases, Plasmid-Based Knockdown of NDRG1. To silence NDRG1 gene expression, two 6 chiefly O -methylguanine-DNA methyltransferase (MGMT), a short-hairpin RNA (shRNA) sequences targeting different sites were cloned key enzyme for resistance to alkylating agents in glioblastoma into the pSUPER-puro vector (11, 12). The sequences are provided in patients. In patients with glioblastoma, MGMT promoter meth- SI Appendix. ylation in tumor tissue was not more predictive for response to alkylating chemotherapy in patients who received concomitant Lentiviral Preparations. Lentiviral particles for the knockdown experiments corticosteroids. were produced by cotransfecting psPAX2, pMD2.G (both Addgene plasmid 12259), and pLKO.1 constructs (TRC1; Sigma-Aldrich) in HEK293T cells using rimary or acquired antitumor therapy resistance is one of the TransIT LT1 (Mirus Bio). Details are given in SI Appendix. Pmajor obstacles in oncology. For glioma, to date, this is pivotal for the standard of care, radiotherapy, and temozolomide Significance (TMZ) alkylating chemotherapy. The DNA repair protein O6- methylguanine-DNA methyltransferase (MGMT) plays a critical N-myc downstream regulated gene 1 (NDRG1) is a central and role in primary resistance to alkylating agents (1, 2). Serving as druggable molecular hub integrating diverse therapy-induced mi- a central signaling hub integrating multiple intracellular and croenvironmental factors to promote resistance toward alkylating extracellular cues, the 289-kDa serine/threonine kinase mam- chemotherapy. We suggest that NDRG1-mediated chemoprotection malian target of rapamycin (mTOR) is an attractive anticancer is achieved via binding and stabilizing methyltransferases, such as target. Activation of the signaling network engaged by the protein O6-methylguanine-DNA methyltransferase. inositol-3 kinase/AKT/mTOR axis frequently occurs by activation of receptor tyrosine kinases (RTK), chiefly the epidermal growth Author contributions: M. Weiler, J.B., M.B., A.v.D., F.W., P.V., M.P., and W.W. designed factor receptor (EGFR) being the most commonly altered RTK in research; M. Weiler, J.B., S.P., F.S., M.C., S.L., L.B., G.S., V.E., M.J., S.H., M.O., P.R., P.-N.P., M.R., A.A., and W.W. performed research; J.B., S.P., F.S., S.L., L.B., G.S., M.O., T.K., M.S., F.L., glioblastomas. However, mere inhibition of EGFR or mTOR has and F.W. contributed new reagents/analytic tools; M. Weiler, J.B., S.P., F.S., M.C., S.L., L.B., been ineffective in glioblastomas. G.S., V.E., M.J., S.H., M.O., C.M., T.H., P.R., P.-N.P., M.R., T.K., M.S., A.A., F.L., M.B., A.v.D., The hypoxic microenvironment has been proposed to serve as M. Weller, P.V., M.P., and W.W. analyzed data; and M. Weiler, J.B., G.S., V.E., M.J., C.M., germ center for more aggressive and therapy-resistant tumor cell T.H., M. Weller, P.V., M.P., and W.W. wrote the paper. phenotypes (3) especially preventing the efficacy of radiotherapy The authors declare no conflict of interest. (4, 5). Hypoxia induces resistance to several anticancer agents in *This Direct Submission article had a prearranged editor. neurons (6) but also in glioma cells (7). In general, hypoxia 1M. Weiler, J.B., and S.P. contributed equally to this work. causes the accumulation of the transcription factor hypoxia- 2To whom correspondence should be addressed. E-mail: [email protected] inducible factor (HIF)-1 leading to the expression of hypoxia- heidelberg.de. inducible genes such as those for vascular endothelial growth This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. MEDICAL SCIENCES factor (VEGF) and N-myc downstream regulated gene 1 (NDRG1) 1073/pnas.1314469111/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1314469111 PNAS | January 7, 2014 | vol. 111 | no. 1 | 409–414 Downloaded by guest on October 3, 2021 Cloning of NDRG1 Variants. NDRG1 dephospho-variants were generated by using site-directed mutagenesis PCR and changing the codons of the phospho-sites Thr and Ser to Val and Ala, respectively. Two different phosphorylation- deficient variants, NDRG1-T346V-T356V and NDRG1-T328V-S330A-T346V-T356V, were generated. Immunoblot. Preparation of cell lysates and immunoblots were performed as described before (12). Antibodies are given in SI Appendix, Table S8. Proximity Ligation Assay. T98G and LN-229 cells (n = 2 × 104) were confluently grown at O2 of 1% (vol/vol) on coverslips for 72 h. Fixation was done using 30 min Cytofixx Pump Spray cell path and 30 min 4% (vol/vol) para- formaldehyde. For detection the Red Duolink In Situ Proximity Ligation Assay (PLA) Kit was performed according to manufacturer´s instructions with anti-NDRG1 polyclonal rabbit (Sigma-Aldrich) and mouse anti-MGMT (Life Technologies) applied for 12 h. Mounting was done with VECTASHIELD HardSet Mounting Medium with DAPI. Animal Experiments, Image Processing, and Histology. All animal work was approved by the governmental authorities (Regierungspräsidium Karlsruhe) and supervised by institutional animal protection officials in accordance with the National Institutes of Health guidelines given in Guide for the Care and Use of Laboratory Animals. Details are provided in SI Appendix. Clinical Data. All clinically related research in this manuscript is covered by the Ethical Vote for the UKT-05 (13), NOA-04 (14), and NOA-08 (15) trials. Statistical Analysis. Quantitative in vitro data are expressed as mean ± SD (SD), as indicated. All in vitro experiments reported here represent at least three independent replications performed in triplicate if not otherwise stated. Statistical significance was assessed by two-sided Student’s t test or ANOVA (Microsoft Excel). Values of P < 0.05 were considered significant and asterisked without correction for multiple statistical tests. Mouse glioma volumes were corrected for outliers using Grubbs’ test. Survival data were plotted by the Kaplan–Meier method and analyzed by the log-rank test. SigmaPlot Software was used for all analyses. Results Fig. 1. NDRG1 is a hypoxia-associated chemoresistance marker in glioma.
Load more

Recommended publications
  • Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
    Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected].
    [Show full text]
  • Profiling Data
    Compound Name DiscoveRx Gene Symbol Entrez Gene Percent Compound Symbol Control Concentration (nM) BSJ-03-123 AAK1 AAK1 94 1000 BSJ-03-123 ABL1(E255K)-phosphorylated ABL1 79 1000 BSJ-03-123 ABL1(F317I)-nonphosphorylated ABL1 89 1000 BSJ-03-123 ABL1(F317I)-phosphorylated ABL1 98 1000 BSJ-03-123 ABL1(F317L)-nonphosphorylated ABL1 86 1000 BSJ-03-123 ABL1(F317L)-phosphorylated ABL1 89 1000 BSJ-03-123 ABL1(H396P)-nonphosphorylated ABL1 76 1000 BSJ-03-123 ABL1(H396P)-phosphorylated ABL1 90 1000 BSJ-03-123 ABL1(M351T)-phosphorylated ABL1 100 1000 BSJ-03-123 ABL1(Q252H)-nonphosphorylated ABL1 56 1000 BSJ-03-123 ABL1(Q252H)-phosphorylated ABL1 97 1000 BSJ-03-123 ABL1(T315I)-nonphosphorylated ABL1 100 1000 BSJ-03-123 ABL1(T315I)-phosphorylated ABL1 85 1000 BSJ-03-123 ABL1(Y253F)-phosphorylated ABL1 100 1000 BSJ-03-123 ABL1-nonphosphorylated ABL1 60 1000 BSJ-03-123 ABL1-phosphorylated ABL1 79 1000 BSJ-03-123 ABL2 ABL2 89 1000 BSJ-03-123 ACVR1 ACVR1 100 1000 BSJ-03-123 ACVR1B ACVR1B 95 1000 BSJ-03-123 ACVR2A ACVR2A 100 1000 BSJ-03-123 ACVR2B ACVR2B 96 1000 BSJ-03-123 ACVRL1 ACVRL1 84 1000 BSJ-03-123 ADCK3 CABC1 90 1000 BSJ-03-123 ADCK4 ADCK4 91 1000 BSJ-03-123 AKT1 AKT1 100 1000 BSJ-03-123 AKT2 AKT2 98 1000 BSJ-03-123 AKT3 AKT3 100 1000 BSJ-03-123 ALK ALK 100 1000 BSJ-03-123 ALK(C1156Y) ALK 78 1000 BSJ-03-123 ALK(L1196M) ALK 100 1000 BSJ-03-123 AMPK-alpha1 PRKAA1 93 1000 BSJ-03-123 AMPK-alpha2 PRKAA2 100 1000 BSJ-03-123 ANKK1 ANKK1 89 1000 BSJ-03-123 ARK5 NUAK1 98 1000 BSJ-03-123 ASK1 MAP3K5 100 1000 BSJ-03-123 ASK2 MAP3K6 92 1000 BSJ-03-123 AURKA
    [Show full text]
  • The DNA Methylation Landscape of Glioblastoma Disease Progression Shows Extensive Heterogeneity in Time and Space
    bioRxiv preprint doi: https://doi.org/10.1101/173864; this version posted August 9, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space Johanna Klughammer1*, Barbara Kiesel2,3*, Thomas Roetzer3,4, Nikolaus Fortelny1, Amelie Kuchler1, Nathan C. Sheffield5, Paul Datlinger1, Nadine Peter3,4, Karl-Heinz Nenning6, Julia Furtner3,7, Martha Nowosielski8,9, Marco Augustin10, Mario Mischkulnig2,3, Thomas Ströbel3,4, Patrizia Moser11, Christian F. Freyschlag12, Jo- hannes Kerschbaumer12, Claudius Thomé12, Astrid E. Grams13, Günther Stockhammer8, Melitta Kitzwoegerer14, Stefan Oberndorfer15, Franz Marhold16, Serge Weis17, Johannes Trenkler18, Johanna Buchroithner19, Josef Pichler20, Johannes Haybaeck21,22, Stefanie Krassnig21, Kariem Madhy Ali23, Gord von Campe23, Franz Payer24, Camillo Sherif25, Julius Preiser26, Thomas Hauser27, Peter A. Winkler27, Waltraud Kleindienst28, Franz Würtz29, Tanisa Brandner-Kokalj29, Martin Stultschnig30, Stefan Schweiger31, Karin Dieckmann3,32, Matthias Preusser3,33, Georg Langs6, Bernhard Baumann10, Engelbert Knosp2,3, Georg Widhalm2,3, Christine Marosi3,33, Johannes A. Hainfellner3,4, Adelheid Woehrer3,4#§, Christoph Bock1,34,35# 1 CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. 2 Department of Neurosurgery, Medical University of Vienna, Vienna, Austria. 3 Comprehensive Cancer Center, Central Nervous System Tumor Unit, Medical University of Vienna, Austria. 4 Institute of Neurology, Medical University of Vienna, Vienna, Austria. 5 Center for Public Health Genomics, University of Virginia, Charlottesville VA, USA. 6 Department of Biomedical Imaging and Image-guided Therapy, Computational Imaging Research Lab, Medical University of Vi- enna, Vienna, Austria.
    [Show full text]
  • NDRG2 Combined with EGFR Improved Its Prognostic Value for Lung Adenocarcinoma
    NDRG2 combined with EGFR improved its prognostic value for lung adenocarcinoma Bo Yang ( [email protected] ) Tianjin First Central Hospital https://orcid.org/0000-0003-0052-048X Xiao-Ping Li Tianjin First Central Hospital Hong-Gang Zhou Nankai University College of Pharmacy Tao Jiang Fourth Military Medical University Ting Xiao Nankai University College of Pharmacy Yu-Li Wei Nankai University College of Pharmacy Liang Zhang Tianjin First Central Hospital Wen-Chen Wang PLA Army General Hospital Wei-Dong Zhang Tianjin First Central Hospital Research article Keywords: N-Myc downstream-regulated gene2; Epidermal growth factor receptor; Adenocarcinoma; Prognosis Posted Date: September 10th, 2019 DOI: https://doi.org/10.21203/rs.2.14181/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/10 Abstract Background N-Myc downstream-regulated gene2 (NDRG2) plays an important role in lung adenocarcinoma (LUAD). Epidermal growth factor receptor (EGFR) mutation has signicantly improved prognosis in patients with adenocarcinoma. We aimed to elucidate the clinical value of NDRG2/EGFR as a prediction of prognosis in patients with lung adenocarcinoma. Materials and Methods Immunohistochemistry and western blot analysis were conducted to detect the expression of NDRG2 protein. Association between NDRG2/EGFR expression and clinicopathological parameters of the patients were examined. Serum Carcinoembryonic antigen (CEA) level was examined prior to treatment in patients with LUAD. Patients’ survival rate was assessed by Kaplan–Meier. Candidates for independent prognostic biomarkers were analyzed using a COX proportional hazard model. Results NDRG2 levels were signicantly decreased in patients with lung adenocarcinoma. NDRG2 levels were positively correlated with CEA and EGFR.
    [Show full text]
  • Protein Kinase C As a Paradigm Alexandra C
    Biochem. J. (2003) 370, 361–371 (Printed in Great Britain) 361 REVIEW ARTICLE Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm Alexandra C. NEWTON1 Department of Pharmacology, University of California at San Diego, La Jolla, CA 92093-0640, U.S.A. Phosphorylation plays a central role in regulating the activation down-regulation of PKC as a paradigm for how these sites and signalling lifetime of protein kinases A, B (also known as control the function of the ABC kinases. Akt) and C. These kinases share three conserved phosphorylation motifs: the activation loop segment, the turn motif and the Key words: phosphoinositide 3-kinase, phosphoinositide-depen- hydrophobic motif. This review focuses on how phosphorylation dent kinase-1 (PDK-1), phosphorylation motif, protein kinase A at each of these sites regulates the maturation, signalling and (PKA), protein kinase B (PKB)\Akt, protein kinase C (PKC). INTRODUCTION by phosphorylation as a paradigm for control of ABC kinase function by phosphorylation. Almost half a century ago Krebs, Graves and Fischer reported b that the first discovered protein kinase, phosphorylase kinase, ARCHITECTURE OF ABC KINASES was, itself, activated by phosphorylation [1]. Two decades later, Fischer and colleagues showed that the kinase that phosphory- Protein kinases A, B\Akt and C have in common a conserved lates phosphorylase kinase, later named protein kinase A (PKA), kinase core whose function is regulated allosterically by a was also phosphorylated [2]. Reversible control by phosphory- corresponding regulatory moiety (Figure 1). In the case of PKA, lation\dephosphorylation is now firmly established as a fun- the regulatory moiety is a separate polypeptide, whereas the damental mechanism for regulating the function of most of the regulatory determinants are on the same polypeptide as the 500 or so members of the mammalian protein kinase superfamily.
    [Show full text]
  • And Glucocorticoid-Inducible Kinase (Sgk1)" (2007)
    Dartmouth College Dartmouth Digital Commons Open Dartmouth: Published works by Dartmouth faculty Faculty Work 2-14-2007 Regulation of Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) by Serum- and Glucocorticoid- Inducible Kinase (Sgk1) J. Denry Sato Mount Desert Island Biological Laboratory, Salisbury Cove M. Christine Chapline Dartmouth College Renee Thibodeau Dartmouth College Raymond A. Frizzell University of Pittsburgh Bruce A. Stanton Dartmouth College Follow this and additional works at: https://digitalcommons.dartmouth.edu/facoa Part of the Medicine and Health Sciences Commons Dartmouth Digital Commons Citation Sato, J. Denry; Chapline, M. Christine; Thibodeau, Renee; Frizzell, Raymond A.; and Stanton, Bruce A., "Regulation of Human Cystic Fibrosis Transmembrane Conductance Regulator (Cftr) by Serum- and Glucocorticoid-Inducible Kinase (Sgk1)" (2007). Open Dartmouth: Published works by Dartmouth faculty. 3156. https://digitalcommons.dartmouth.edu/facoa/3156 This Article is brought to you for free and open access by the Faculty Work at Dartmouth Digital Commons. It has been accepted for inclusion in Open Dartmouth: Published works by Dartmouth faculty by an authorized administrator of Dartmouth Digital Commons. For more information, please contact [email protected]. Original Paper Cellular Physiology Cell Physiol Biochem 2007;20:91-98 Accepted: February 14, 2007 and Biochemistry Regulation of Human Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Serum- and Glucocorticoid-Inducible Kinase (SGK1) J. Denry Sato1, M. Christine Chapline1,2, Renee Thibodeau1,2, Raymond A. Frizzell1,3 and Bruce A. Stanton1,2 1Mount Desert Island Biological Laboratory, Salisbury Cove, 2Dept. of Physiology, Dartmouth Medical School, Hanover, 3Dept. of Cell Biology and Physiology, University of Pittsburgh Medical School, Pittsburgh Key Words in stimulating CFTR Cl currents.
    [Show full text]
  • Integrative Genomic Analysis Identifies NDRG2 As a Candidate Tumor Suppressor Gene Frequently Inactivated in Clinically Aggressive Meningioma
    Research Article Integrative Genomic Analysis Identifies NDRG2 as a Candidate Tumor Suppressor Gene Frequently Inactivated in Clinically Aggressive Meningioma Eriks A. Lusis,1 Mark A. Watson,2 Michael R. Chicoine,3 Meghan Lyman,4 Peter Roerig,5 Guido Reifenberger,5 David H. Gutmann,4 and Arie Perry1 1Division of Neuropathology, Departments of 2Pathology and Immunology, 3Neurosurgery, and 4Neurology, Washington University School of Medicine, St. Louis, Missouri; and 5Department of Neuropathology, Heinrich-Heine-University, Du¨sseldorf, Germany Abstract and TSLC1 are also common (2, 4–6). However, there are few Although meningiomas are common central nervous system known genetic changes associated with the malignant progression tumors, little is known about the genetic events responsible of meningioma. Although losses of chromosomal arms 14q and 1p for malignant progression. In this study, we employed gene are common in anaplastic tumors (WHO grade III) and are expression profiling to identify transcripts whose expression generally associated with poor prognosis (7, 8), the relevant tumor was lost in anaplastic (WHO grade III) versus benign (WHO suppressor genes that map to these loci have not been identified. grade I) meningioma. Approximately 40% of genes down- Loss of heterozygosity studies have had limited success in regulated in anaplastic meningioma were localized to chro- identifying minimal regions of deletion, in part, due to the fact mosomes 1p and 14q. One specific gene located at 14q11.2, that the entire chromosome or chromosomal arm is lost in most NDRG2, was consistently down-regulated in grade III menin- examples. In the current study, we used a strategy combining expression profiling with known cytogenetic alterations, leading gioma, a finding which we validated at both the transcript and protein levels in independent sets of clinically and patholog- to the identification of NDRG2 as a potential meningioma- ically diverse meningiomas.
    [Show full text]
  • Mtor Signaling in Metabolism and Cancer
    cells Editorial mTOR Signaling in Metabolism and Cancer Shile Huang 1,2 1 Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA; [email protected]; Tel.: +1-318-675-7759 2 Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA Received: 10 October 2020; Accepted: 13 October 2020; Published: 13 October 2020 Abstract: The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, is a central regulator for human physiological activity. Deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases. The papers published in this special issue summarize the current understanding of the mTOR pathway and its role in the regulation of tissue regeneration, regulatory T cell differentiation and function, and different types of cancer including hematologic malignancies, skin, prostate, breast, and head and neck cancer. The findings highlight that targeting the mTOR pathway is a promising strategy to fight against certain human diseases. Keywords: mTOR; PI3K; Akt; tissue regeneration; regulatory T cells; tumor; photodynamic therapy The mechanistic/mammalian target of rapamycin (mTOR), a serine/threonine kinase, integrates environmental cues such as hormones, growth factors, nutrients, oxygen, and energy, regulating cell growth, proliferation, survival, motility and differentiation as well as metabolism (reviewed in [1,2]). Evidence has demonstrated that deregulated mTOR signaling is implicated in a variety of disorders, such as cancer, obesity, diabetes, and neurodegenerative diseases (reviewed in [1,2]). Current knowledge indicates that mTOR functions at least as two distinct complexes (mTORC1 and mTORC2) in mammalian cells.
    [Show full text]
  • Research2007herschkowitzetvolume Al
    Open Access Research2007HerschkowitzetVolume al. 8, Issue 5, Article R76 Identification of conserved gene expression features between comment murine mammary carcinoma models and human breast tumors Jason I Herschkowitz¤*†, Karl Simin¤‡, Victor J Weigman§, Igor Mikaelian¶, Jerry Usary*¥, Zhiyuan Hu*¥, Karen E Rasmussen*¥, Laundette P Jones#, Shahin Assefnia#, Subhashini Chandrasekharan¥, Michael G Backlund†, Yuzhi Yin#, Andrey I Khramtsov**, Roy Bastein††, John Quackenbush††, Robert I Glazer#, Powel H Brown‡‡, Jeffrey E Green§§, Levy Kopelovich, reviews Priscilla A Furth#, Juan P Palazzo, Olufunmilayo I Olopade, Philip S Bernard††, Gary A Churchill¶, Terry Van Dyke*¥ and Charles M Perou*¥ Addresses: *Lineberger Comprehensive Cancer Center. †Curriculum in Genetics and Molecular Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ‡Department of Cancer Biology, University of Massachusetts Medical School, Worcester, MA 01605, USA. reports §Department of Biology and Program in Bioinformatics and Computational Biology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. ¶The Jackson Laboratory, Bar Harbor, ME 04609, USA. ¥Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. #Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA. **Department of Pathology, University of Chicago, Chicago, IL 60637, USA. ††Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132, USA. ‡‡Baylor College of Medicine, Houston, TX 77030, USA. §§Transgenic Oncogenesis Group, Laboratory of Cancer Biology and Genetics. Chemoprevention Agent Development Research Group, National Cancer Institute, Bethesda, MD 20892, USA. Department of Pathology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Section of Hematology/Oncology, Department of Medicine, Committees on Genetics and Cancer Biology, University of Chicago, Chicago, IL 60637, USA.
    [Show full text]
  • Original Article N-Myc Downstream-Regulated Gene 2 Is Related to Insulin Resistance Through IL-6/STAT3 Pathways in Type 2 Diabetic Mice
    Int J Clin Exp Med 2019;12(4):3409-3419 www.ijcem.com /ISSN:1940-5901/IJCEM0088700 Original Article N-myc downstream-regulated gene 2 is related to insulin resistance through IL-6/STAT3 pathways in type 2 diabetic mice Xingxing Zhang1,2*, Pengpeng Jin3*, Weihui Yu1, Qi Zhou1, Xuejiang Gu1, Xiong Chen1, Shuangxing Hou4, Cai Lin2,5 1Department of Endocrinology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; 2Center of Diabetic Foot, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China; 3Center of Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, 2800 Gongwei Road, Shanghai 201399, China; 4Department of Neurology, Shanghai Pudong Hospital, Fu- dan University Pudong Medical Center, 2800 Gongwei Road, Pudong, Shanghai 201399, China; 5Burn and Wound Healing Center, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, Zhejiang Province, China. *Equal contributors. Received November 20, 2018; Accepted January 8, 2019; Epub April 15, 2019; Published April 30, 2019 Abstract: N-myc downstream-regulated gene 2 (Ndrg2) is related to cell development. Previous studies have shown that Ndrg2 is highly expressed in pancreatic β cells. However, whether Ndrg2 participates in the pathogenesis of type 2 diabetic mellitus remains unknown. The current study hypothesized that Ndrg2 may participate in the patho- genesis of type 2 diabetic mellitus (T2DM) through inflammatory related IL-6/STAT3 pathways. Mice were divided into the diabetic and control group (normal mice). Diabetic mice were induced by a high-fat diet for 12 weeks, while the control group was feed with normal diet. Body weight, blood biochemical indexes, and IL-6 levels of the two groups were examined.
    [Show full text]
  • PRODUCTS and SERVICES Target List
    PRODUCTS AND SERVICES Target list Kinase Products P.1-11 Kinase Products Biochemical Assays P.12 "QuickScout Screening Assist™ Kits" Kinase Protein Assay Kits P.13 "QuickScout Custom Profiling & Panel Profiling Series" Targets P.14 "QuickScout Custom Profiling Series" Preincubation Targets Cell-Based Assays P.15 NanoBRET™ TE Intracellular Kinase Cell-Based Assay Service Targets P.16 Tyrosine Kinase Ba/F3 Cell-Based Assay Service Targets P.17 Kinase HEK293 Cell-Based Assay Service ～ClariCELL™ ～ Targets P.18 Detection of Protein-Protein Interactions ～ProbeX™～ Stable Cell Lines Crystallization Services P.19 FastLane™ Structures ～Premium～ P.20-21 FastLane™ Structures ～Standard～ Kinase Products For details of products, please see "PRODUCTS AND SERVICES" on page 1～3. Tyrosine Kinases Note: Please contact us for availability or further information. Information may be changed without notice. Expression Protein Kinase Tag Carna Product Name Catalog No. Construct Sequence Accession Number Tag Location System HIS ABL(ABL1) 08-001 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) BTN BTN-ABL(ABL1) 08-401-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ABL(ABL1) [E255K] HIS ABL(ABL1)[E255K] 08-094 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) HIS ABL(ABL1)[T315I] 08-093 Full-length 2-1130 NP_005148.2 N-terminal His Insect (sf21) ABL(ABL1) [T315I] BTN BTN-ABL(ABL1)[T315I] 08-493-20N Full-length 2-1130 NP_005148.2 N-terminal DYKDDDDK Insect (sf21) ACK(TNK2) GST ACK(TNK2) 08-196 Catalytic domain
    [Show full text]
  • Modulation of TORC2 Signaling by a Conserved Lkb1 Signaling Axis in Budding Yeast
    | INVESTIGATION Modulation of TORC2 Signaling by a Conserved Lkb1 Signaling Axis in Budding Yeast Maria Alcaide-Gavilán,*,1 Rafael Lucena,*,1,2 Katherine A. Schubert,* Karen L. Artiles,*,3 Jessica Zapata,*,†,4 and Douglas R. Kellogg*,2 *Department of Molecular, Cell, and Developmental Biology, University of California, Santa Cruz, California 95064 and †NantOmics, Santa Cruz, CA 95064 ORCID IDs: 0000-0001-9102-4857 (M.A.-G.); 0000-0003-2050-0611 (R.L.); 0000-0003-2676-8838 (K.A.S.); 0000-0002-1674-064X (K.L.A.); 0000-0001-9567-3539 (J.Z.); 0000-0002-5050-2194 (D.R.K.) ABSTRACT Nutrient availability, growth rate, and cell size are closely linked. For example, in budding yeast, the rate of cell growth is proportional to nutrient availability, cell size is proportional to growth rate, and growth rate is proportional to cell size. Thus, cells grow slowly in poor nutrients and are nearly half the size of cells growing in rich nutrients. Moreover, large cells grow faster than small cells. A signaling network that surrounds TOR kinase complex 2 (TORC2) plays an important role in enforcing these proportional relationships. Cells that lack components of the TORC2 network fail to modulate their growth rate or size in response to changes in nutrient availability. Here, we show that budding yeast homologs of the Lkb1 tumor suppressor kinase are required for normal modulation of TORC2 signaling in response to changes in carbon source. Lkb1 kinases activate Snf1/AMPK to initiate transcription of genes required for utilization of poor carbon sources. However, Lkb1 influences TORC2 signaling via a novel pathway that is independent of Snf1/AMPK.
    [Show full text]